Egetis Therapeutics
Develops and commercializes treatments for serious and rare diseases.
EGTX | ST
Overview
Corporate Details
- ISIN(s):
- SE0003815604
- LEI:
- 549300RZCKGWRUBPMY22
- Country:
- Sweden
- Address:
- Klara Norra Kyrkogata 26, 111 22 Stockholm
- Website:
- https://www.egetis.com/
- Sector:
- Manufacturing
Description
Egetis Therapeutics is an innovative and integrated pharmaceutical company focused on developing and commercializing treatments for serious and rare diseases with significant unmet medical needs. The company's strategy centers on advancing drug candidates through late-stage clinical development to market approval. Its primary asset, Emcitate (tiratricol), is a first-in-class drug candidate in late-stage development for the treatment of Monocarboxylate Transporter 8 (MCT8) deficiency, a rare congenital disorder of thyroid hormone transport.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-12-16 17:20 |
Issuance and repurchase of class C shares for incentive programs
|
English | 46.2 KB | ||
| 2024-12-12 15:43 |
Egetis receives positive CHMP opinion for Emcitate® (tiratricol) for the treatm…
|
English | 74.7 KB | ||
| 2024-12-12 15:43 |
Egetis erhåller positivt CHMP-utlåtande för Emcitate® (tiratricol) för behandli…
|
Swedish | 75.4 KB | ||
| 2024-11-08 07:00 | English | 3.9 MB | |||
| 2024-10-31 18:22 | English | 33.8 KB | |||
| 2024-10-31 16:15 |
Egetis’ Nomination Committee for the 2025 Annual General Meeting
|
English | 58.2 KB | ||
| 2024-10-31 16:15 |
Egetis valberedning utsedd inför årsstämman 2025
|
Swedish | 58.2 KB | ||
| 2024-10-31 08:25 |
Ändring av antalet aktier och röster i Egetis Therapeutics
|
Swedish | 65.6 KB | ||
| 2024-10-31 04:09 | English | 34.2 KB | |||
| 2024-10-28 08:34 |
Egetis Therapeutics offentliggör prospekt för upptagande till handel av aktier …
|
Swedish | 57.2 KB | ||
| 2024-10-25 14:45 |
Kommuniké från Egetis Therapeutics extra bolagsstämma 2024
|
Swedish | 58.7 KB | ||
| 2024-10-04 08:00 |
Change in the Board of Directors of Egetis Therapeutics
|
English | 60.9 KB | ||
| 2024-10-04 08:00 |
Förändring i styrelsen för Egetis Therapeutics
|
Swedish | 60.3 KB | ||
| 2024-09-30 23:17 |
NOTICE OF EXTRAORDINARY GENERAL MEETING IN EGETIS THERAPEUTICS AB (PUBL)
|
English | 80.1 KB | ||
| 2024-09-30 22:55 |
Egetis Therapeutics has successfully carried out directed share issuances amoun…
|
English | 92.2 KB |
Automate Your Workflow. Get a real-time feed of all Egetis Therapeutics filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Egetis Therapeutics
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Egetis Therapeutics via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-09 | Yilmaz Mahshid | Other | Sell | 39,753 | 268,332.75 SEK |
| 2025-01-08 | Yilmaz Mahshid | Other | Sell | 98,567 | 653,499.21 SEK |
| 2025-01-07 | Yilmaz Mahshid | Other | Sell | 74,769 | 507,681.51 SEK |
| 2024-10-07 | Nicklas Westerholm | Other | Buy | 10,142 | 43,103.50 SEK |
| 2024-10-07 | Yilmaz Mahshid | Other | Buy | 10,000 | 42,250.00 SEK |
| 2023-07-07 | Henrik Krook | Other | Buy | 33,594 | 133,704.12 SEK |
| 2023-07-06 | Christian Sonesson | Other | Buy | 3,616 | 14,391.68 SEK |
| 2023-07-06 | Christian Sonesson | Other | Buy | 2,000 | 7,920.00 SEK |
| 2023-07-05 | Christian Sonesson | Other | Buy | 1,384 | 5,452.96 SEK |
| 2023-07-04 | Nicklas Westerholm | Other | Buy | 15,350 | 60,632.50 SEK |
Peer Companies
